FDA: More high blood pressure medications recalled due to cancer risk

Another drug has been added to a recall for medication used to treat high blood pressure.

Torrent Pharmaceuticals Limited is recalling several batches of  Losartan Potassium tablets, the FDA announced Thursday.

Losartan is reportedly used to treat hypertension, hypertensive patients with Left Ventricular Hypertrophy, and for the treatment of nephropathy in Type 2 diabetic patients.

The recall states that “trace amounts” of N-Methylnitrosobutyric acid, which is a known carcinogen, have been found in the medication, as well as several others that were recalled last year.

The FDA warns that patients using any of the drugs included in the recall should contact their doctor before stopping the use of  Losartan completely.

Torrent Pharmaceuticals Limited is recalling the following medications:

Losartan Potassium Tablets, USP 50mg, 1000 count

  • NDC: 13668-409-10
  • Batch No.: 4DU2E009
  • Expiration: 12/31/2020

Losartan Potassium Tablets, USP 100mg, 90 count

  • NDC: 13668-115-90
  • Batch No.: 4DU3E009
  • Expiration: 12/31/2020

Losartan Potassium Tablets, USP 100mg, 1000 count

  • NDC: 13668-115-10
  • Batch No.: 4DU3D018
  • Expiration: 02/28/2021

Losartan Potassium / Hydrochlorothiazide Tablets, USP 50mg/12.5mg, 90 count

  • NDC: 13668-116-90
  • Batch No.: BEF7D051
  • Expiration: 11/30/2020

Losartan Potassium / Hydrochlorothiazide Tablets, USP 100mg/25mg, 90 count

  • NDC: 13668-118-90
  • Batch No.: 4P04D007
  • Expiration: 07/31/2020

Anyone with questions regarding the recall or who wants to report an adverse reaction to the drug is asked to contact Torrent Pharmaceuticals Limited at (800) 912-9561.

Product photos:

Continuing coverage, here.

Notice: you are using an outdated browser. Microsoft does not recommend using IE as your default browser. Some features on this website, like video and images, might not work properly. For the best experience, please upgrade your browser.